Abstract
This study addresses the current trend of essential oils in alternative medicine using the non-chordate model Drosophila melanogaster. Following the three R’s principles, it proposes non-chordate models to fill knowledge gaps on essential oil toxicity. Copaiba, lavender, and ginger essential oils are evaluated for effects on D. melanogaster lifespan, climbing ability, and brain structure, while their anti-inflammatory properties are also analyzed. Results show dose-related differences: higher concentrations (0.25% v/v) cause brain deterioration and impaired climbing, while lower concentrations (0.0625% v/v for copaiba and ginger; 0.125% for lavender) have no effect on climbing or brain structure. Lavender oil significantly extends lifespan and maintains anti-inflammatory activity when ingested, underscoring its therapeutic potential. These findings highlight the importance of D. melanogaster as a model for studying essential oil properties, potentially replacing chordate models. In addition, this research advances alternative remedies for currently incurable diseases, with lavender oil emerging as a promising candidate for drug discovery.
Introduction
In 2021, the essential oils (EOs) market size was valued at $20.3 billion, with an estimated growth of 7.4% by 2028, due to their increasing use in industries such as food and beverages, cosmetics, and aromatherapy. In addition, because they are considered more "natural" than most commonly used medicines, their medical interest is increasing, and essential oils are slowly replacing drugs and medicines due to their reduced risk of side effects. Essential oils are basically substances extracted by distillation from different parts of plants, such as leaves, fruits, roots or flowers, and are composed of a mixture of hydrocarbons, ethers, esters, alcohols, aldehydes, phenols and terpenes [1,2].
Essential oils have a variety of different properties, including anti-inflammatory, antioxidant, antibiotic, and antiviral activities. The EOs extracted from lavender (Lavandula angustifolia), copaiba (Copaifera reticulata, officinalis, coriacea, and langsdorffii) and ginger (Zingiber officinale) all exhibited these activities both in vitro and in vivo [3–9], making them interesting targets for drug discovery that could be used to treat diseases that currently have no cure or treatment, such as neurodegenerative diseases and cancer. However, despite their widespread use and potential benefits, there is still a significant lack of information regarding the safety and efficacy of essential oils. Reports of adverse effects such as neurotoxicity, hepatotoxicity and reproductive abnormalities highlight the need for further research in this area [10–14].
To generate this knowledge, it is necessary to use animals as model organisms. However, this has been the subject of intense scientific debate due to ethical and legislative differences between countries. Data collected by the UK government in 2021 showed that more than 3 million procedures were performed on animals, of which 57% were experimental procedures, using animals in studies such as drug safety testing and the development of treatments [15].
Since the use of animals is essential, it is not always possible to avoid animal testing in order to obtain the same results. Considering the replacement principle of the "Three R’s" guidelines established in 1959, the use of non-chordate animals (flies, worms) instead of chordates (mice, dogs, primates) is one of the possibilities to conduct research in a more ethical way, considering that non-chordates are less sentient animals [16]. The Drosophila melanogaster is a model organism that has already been used to test the toxicity of different compounds, such as metals and plant extracts [17,18]. Some of the advantages of using this animal are its fast life cycle, its cheap maintenance in laboratories and a genome with significant human homology [18–20]. Another advantage of using this model organism is the UAS-Gal4 system. First introduced in 1993, this system uses the yeast transcriptional activator Gal4, randomly inserted into the D. melanogaster genome, along with genes containing Gal4 binding sites, in this case UAS as an enhancer of the target gene. These genes are activated in cells expressing Gal4, allowing analysis of the phenotype produced by their expression. Expression of the yeast transcriptional activator could also be used alongside a driver gene to target the activation of target genes to specific organs or tissues [21].
In addition, the fruit fly model allows the evaluation of its behavior through assays already well established in the literature, such as the larval crawling assay, the courtship and mating assay, and the climbing assay, also known as the RING (Rapid Iterative Negative Geotaxis) test [22]. Because this test relies on the motor reflex of the flies, it can be used to detect, for example, neurodegeneration that might impair their motor abilities [23].
There have been some experiments using essential oils and fruit flies as a model organism, specifically the species D. melanogaster and Drosophila suzukii [24–26]. However, while these studies have analyzed the larvicidal and insecticidal effects of essential oils, our purpose on this study is to evaluate their toxicity and therapeutic potential in this model, aiming to propose this animal model as a replacement for chordate ones.
Therefore, this study aims to establish D. melanogaster as a viable model organism for studying the effects of essential oils in vivo. Specifically, we evaluate the toxicity and potential therapeutic effects of copaiba, lavender, and ginger essential oils on D. melanogaster lifespan, behavior, and brain morphology, as well as their anti-inflammatory activity, contributing to the scientific development and respecting the principles of the use of animals in research, especially the reduction of the number of chordate animals, as well as the replacement in many cases by a non-chordate in animal experiments.
Materials and methods
Drosophila stock and culture
D. melanogaster flies from the Canton S and w1118 (Stock #3605) strains were obtained from the Bloomington Stock Center, Indianapolis, IN. The group also used the GMR-GAL4 > UAS-Eiger stock kindly provided to our laboratory by Dr. Masayuki Miura of the University of Tokyo (Tokyo, Japan).
Animals were reared on a standard cornmeal medium, and the tests were performed on a mashed potato medium containing 75% powdered mashed potato (Yoki®), 15% yeast extract, 9.3% glucose and 0.7% nipagin. The flies were maintained in a BOD incubator at a controlled temperature of 25°C with a 12h/12h light/dark cycle. Flies were anesthetized with cold or ethyl ether for sex determination and mating.
Groups of 30 male adult w1118 flies (0 to 3 days post-emergence) were used for all of the following tests, except for the toxicity evaluation where groups of 15 male and 15 female adult w1118 flies (0 to 3 days post-emergence) were used. Each test lasted for 15 days, since the group aimed at a chronic treatment with the essential oils. All experiments were performed on three independent triplicates.
Essential oils and solutions preparation
Essential oils of copaiba (Copaifera sp.), ginger (Zingiber officinale), and lavender (Lavandula angustifolia) (döTerra, Utah, USA) were used, diluted with water to different concentrations for each assay and treatment (0.0625% v/v, 0.125% v/v, 0.25% v/v, and 0.5% v/v), with the solution being thoroughly mixed by vortexing for 10 seconds to disperse the oil in the water each time it was pipetted. Both EOs and their dilutions were stored at room temperature and protected from light to prevent degradation. Chromatography charts of the EOs provided by döTerra can be found in the Supporting Information (S1–S3 Datasets).
Toxicity evaluation of the essential oils
The first step, prior to treating the flies, was to determine the toxicity of each of the oils at different concentrations. Each essential oil was tested at concentrations of 0.0625% v/v, 0.125% v/v, 0.25% v/v, and 0.5% v/v. Groups of 30 adult w1118 flies (0 to 3 days post-emergence) were separated into vials for each treatment in triplicate, with a 1:1 ratio of males to females.
Each vial contained mashed potato medium prepared with 5 mL of water (control group) or 5 mL of the EOs solutions. Flies were fed on the food prepared with these solutions for 15 days and transferred to vials containing fresh food every 2 to 3 days. The number of dead flies was counted each time they were transferred to a new vial.
Lifespan analysis
To understand how consumption of the EOs would alter the lifespan of the flies, a lifespan assay was performed. Male flies of the w1118 stock (0-to-1-day post-emergence) were separated into groups of 30 and fed on mashed potato medium prepared with the solutions at 0.0625% v/v for the copaiba and ginger EOs and 0.125% v/v for the lavender EO.
Similar to the toxicity evaluation, the flies were maintained on vials containing mashed potato medium prepared with 5 mL of water (control group) and 5 mL of the EOs solutions. Flies were transferred to vials containing fresh food every 2 to 3 days, and the number of dead flies was counted at each transfer until all flies had died.
Climbing assay
The Rapid Iterative Negative Geotaxis (RING) test was used to determine whether the essential oils diet would cause any changes in the locomotor ability and behavior of the flies, performed as described by Gargano et. al in 2005 [27]. The only modification is that the digital image used to evaluate the position of the flies on the vials was taken 10 seconds after the apparatus was tapped on the surface. This is due to the strain of flies used, w1118, which has a natural retinal degeneration that makes their climbing slower than other strains [28].
To understand how the animal model used would respond to an essential oil diet, the group performed the RING test using two sets of EO concentrations: lower doses that showed no toxicity in the toxicity test and higher doses that caused a greater number of deaths in the toxicity test. For the first, the concentrations used were 0.0625% v/v for the copaiba and ginger EOs and 0.125% v/v for the lavender EO. For the higher dose test, the concentrations used were 0.25% v/v for each essential oil.
The flies were fed on mashed potato medium prepared with the EO solutions at the above concentrations for 15 days, with the RING test performed every 5 days.
Histological analysis
Knowing that the essential oils have small molecules that can cross the blood-brain barrier, the group decided to analyze whether ingesting the EOs could cause any damage to the flies’ brains. Again, we decided to test both higher and lower doses of the essential oils to understand how the D. melanogaster model would respond to different concentrations of EOs.
Males from the w1118 strain were collected from 0 to 1-day post-emergence and divided into groups of 10 flies in triplicates and fed on mashed potato medium prepared with the solutions of EOs. The animals were kept on this diet for 15 days, euthanized with liquid nitrogen and decapitated for preparation of brain tissue slides. The tissues were fixed in paraffin and stained with hematoxylin and eosin for better visualization, following the protocol used by Malta et. al 2022 [29].
The concentrations used were 0.25% v/v for each essential oil for higher doses and 0.0625% v/v for the copaiba and ginger essential oils and 0.125% v/v for the lavender essential oil for the lower doses.
Analysis of the anti-inflammatory properties of the essential oils
Each of the essential oils used in this project has an anti-inflammatory activity already seen in both in vitro and in vivo tests [3–9]. However, the most commonly used animal models are mice and rats.
To analyze whether the D. melanogaster model would also respond to treatment with essential oils by ingestion, we used GMR-GAL4 > UAS Eiger flies as a model of inflammation in which eye degeneration is caused by overexpression of Eiger, a Drosophila ortholog of tumor necrosis factor alpha, in the organ. Assays in these animals are performed on larvae rather than adults because inflammation begins as soon as the animal hatches from the egg.
Flies of the GMR-GAL4 > UAS-Eiger strain were mated for 24 hours in oviposition medium. After this time, the parental flies were removed from the flask and the eggs were collected. These eggs were then placed in vials containing mashed potato medium prepared with solutions of the EOs at 0.025% v/v each. The animals were maintained on this medium for 10 days until the adult flies emerged from the pupae. The animals were then anesthetized with ice, and 60 flies from each group were collected for measurement of eye area using ImageJ software. The Canton S strain was used as a wild-type model for comparison of eye morphology.
Statistical analysis
All statistical tests were performed using GraphPad Prism 8 software. The Mantel-Cox test was used to evaluate the statistical significance of the data for toxicity evaluation and lifespan analysis. Two-way ANOVA test was used for the climbing assay. One-way ANOVA test was used to analyze the anti-inflammatory properties of the essential oils. All values of p < 0.05 were considered significant.
Results
Essential oils demonstrate dose-dependent toxicity in Drosophila flies
Toxicity of essential oils was evaluated by exposing flies to food containing a mixture of water and oils at concentrations of 0.0625%, 0.125%, 0.25%, and 0.5% v/v for 15 days. At a concentration of 0.0625% v/v, lavender essential oil was the only oil that resulted in a higher mortality rate compared to the control group (p<0.05) (Fig 1A). At a concentration of 0.125% v/v, flies exposed to copaiba and ginger essential oils had a mortality rate close to 50% (p<0.001 and p<0.05, respectively), while flies exposed to lavender EO had a mortality rate similar to the control (Fig 1B). At. 0.25% v/v, all three essential oils resulted in higher mortality compared to the control group (copaiba: p<0.05, ginger: p<0.001, and lavender: p<0.0001) (Fig 1C). The result is similar at the 5% v/v concentration, where consumption of all essential oils resulted in more deaths compared to the control group (p<0.0001) (Fig 1D).
Safe concentrations of essential oils have varying effects on Drosophila melanogaster lifespan
To further investigate the effects of safe concentrations of essential oils on Drosophila melanogaster, we performed a lifespan analysis after prolonged exposure. We used concentrations of 0.0625% v/v for copaiba and ginger essential oils and 0.125% v/v for lavender essential oil. Our results showed that copaiba EO did not alter the lifespan or mortality rate of the flies compared to the control group. However, ginger EO caused a higher mortality rate in the flies from the fifteenth day, suggesting that long-term exposure may be toxic to the animals (p<0.01). In contrast, flies that ingested lavender EO had an increase in lifespan of 12 days compared to the control group (p<0.001) (Fig 2).
Essential oils at low concentrations do not affect neuromotor function or brain morphology in flies
We evaluated the effects of safer concentrations of essential oils on neuromotor function and brain morphology in Drosophila melanogaster. The results showed that 0.0625% v/v concentration of ginger and copaiba essential oils and 0.125% v/v concentration of lavender essential oil did not affect the climbing ability of the flies. While copaiba EO had no effect on climbing ability, lavender EO increased climbing ability on days 5 (p<0.001) and 10 (p<0.05) of treatment, and ginger EO increased climbing ability only on day 5 (p<0.01) (Fig 3A–3C).
Furthermore, exposure to these lower doses did not cause any visible brain damage, as there were no vacuoles present in the brain tissue morphology of the treated flies compared to the control group (Fig 3D–3G).
Essential oils cause vacuole formation in Drosophila brain and neuromotor impairment at higher concentrations
During the fifth and tenth days after treatment, the climbing ability of the flies remained relatively unaffected, except for the flies exposed to copaiba essential oil on day five (p<0.05) and ginger essential oil on day ten (p<0.05) (Fig 4A and 4B). However, by day 15, flies exposed to all three essential oils showed a 20% decrease in climbing ability compared to the control group, indicating neuromotor impairment caused by the EOs (copaiba and ginger EOs: p<0.01, and lavender EO: p<0.001) (Fig 4C).
Histological analysis showed that a concentration of 0.25% v/v of the essential oils for 15 days caused neurological damage in the brains of Drosophila melanogaster flies. The presence of vacuoles in the brain tissue suggests that the essential oils may have caused damage to the nervous system, consistent with the neuromotor impairment observed in the climbing assay. The extent of brain damage varied among the three essential oils, with lavender EO producing more prominent vacuoles than the other two oils (Fig 4D–4G).
Lavender essential oil promotes slight recovery of ocular inflammation caused by Eiger protein overexpression in D. melanogaster
A wild-type D. melanogaster eye phenotype, characterized by its large area and round shape (Canton S strain), is shown in Fig 5A. In contrast, Fig 5B shows the eye of an untreated GMR-GAL4 > UAS-Eiger fly, which shows degeneration due to overexpression of Eiger protein in the organ, resulting in loss of shape and area. Visual analysis of flies fed copaiba essential oil (Fig 5C) or ginger essential oil (Fig 5D) showed no significant evidence of reversal of ocular degeneration. However, when flies were fed lavender essential oil, a slight recovery of shape and increased eye area was observed (Fig 5E).
Quantitative analysis using ImageJ software revealed no statistical difference in eye area between the control group (untreated GMR-GAL4 > UAS-Eiger fly) and flies treated with copaiba essential oil or ginger essential oil. However, flies that ingested lavender essential oil had a significantly larger eye area compared to the control group (p<0.0001) (Fig 5F).
Discussion
The essential oils extracted from Copaifera spp, Zingiber officinale and Lavender angustifolia have shown promising results in previous studies regarding their anti-inflammatory, antioxidant and antimicrobial activities, as mentioned above. These results indicate their potential as alternative treatments for diseases and bacterial, fungal and viral control. However, their toxicity still needs to be evaluated in in vivo models to better understand their limitations as potential drugs. One way to fill this information gap is to test their use in model organisms, in this case Drosophila melanogaster.
In the experiments conducted, the D. melanogaster model showed changes in lifespan depending on the amount of essential oil they ingested. While at higher doses all EOs showed toxicity to the flies and reduced their lifespan, at lower doses they did not change it or, for lavender essential oil, increased it. These results indicate that this model can be a useful tool to assess the potential toxicity of essential oils. Furthermore, the observed increase in lifespan in flies that ingested lavender essential oil at lower doses highlights its potential as a natural product for further exploration in drug discovery.
Our investigation revealed that the ingestion of essential oils had a significant effect on the behavior of fruit flies, with climbing ability being particularly affected in a dose-dependent manner. Higher doses of essential oils resulted in impaired climbing ability, likely due to neurotoxicity, as evidenced by vacuoles observed in brain histology of affected flies. These results are consistent with previous studies showing that essential oils can have neurotoxic effects [30–32]. Our results demonstrate that fruit flies can be used to study the effects of essential oils on brain morphology and suggest that neurotoxicity is one of the possible adverse effects of overdosing on copaiba, ginger, and lavender essential oils.
At lower doses of essential oil intake, copaiba and ginger essential oils did not significantly affect the climbing ability of the flies during the 15-day treatment period. However, flies treated with lavender essential oil showed a slight improvement in their climbing ability, consistent with the histological analysis of their brains, where no major changes in morphology were observed. The natural eye degeneration of the w1118 fly strain used in this study leads to slower climbing [28], making the improvement in climbing ability after lavender essential oil treatment particularly noteworthy. These results suggest that lavender essential oil may have a protective effect on retinal degeneration in D. melanogaster. However, further studies are needed to elucidate the underlying mechanisms and to confirm these findings.
Specifically for copaiba, studies analyzing the toxicity of copaiba oleoresin, which shares some of its constituents with the essential oil, found no acute or short-term toxicity in Wistar rats given the oleoresin by gavage at 2000 mg/kg (acute) and 100 mg/kg for 28 days (short-term) [33,34]. It is important to note that although they have the same constituents, essential oils are more concentrated and may have a different effect on animals compared to oleoresin. Unfortunately, studies analyzing the toxicity of essential oils are still scarce, especially in D. melanogaster, so more research is needed in this area.
While previous studies have demonstrated the anti-inflammatory activity of all three essential oils in various applications such as topical and inhalation [7,35–38], our investigation revealed that only lavender essential oil had the potential to restore the area and shape of the eye after ingestion. This observation not only demonstrates the ability of flies to respond to essential oil treatment, but also suggests that lavender EO retains its anti-inflammatory properties even after ingestion, unlike ginger and copaiba EO. These findings provide opportunities for further research on lavender EO because several D. melanogaster strains can simulate human diseases for which there are no effective treatments or cures, including neurodegenerative diseases that involve inflammation as a pathological mechanism (e.g., Alzheimer’s, Parkinson’s, and Huntington’s diseases). Notably, these D. melanogaster models are well established in the literature and serve as reliable sources of information on potential treatments for these diseases [39–41].
Nevertheless, this study has some limitations. The group analyzed changes in brain morphology which could be useful for future research on essential oils. However, further research is necessary to analyze the impact of essential oils on other organs, particularly the gastrointestinal tract. Moreover, the essential oils used have antimicrobial activity, which implies that they might have disturbed the flies’ gut microbiota, as mentioned above. Dysbiosis of the microbiota is known to not only disrupt intestinal functions but also impact brain function via the gut-brain axis [42–47]. The group aims to investigate these questions in future research.
It is also important to mention that since the essential oils were administered to the flies through their food ad libitum, we could not ensure that the flies ingested the same amount of essential oil. A food intake analysis could be performed in the future to avoid this bias and to understand if the presence of the EOs on their food affects the amount of food they consume.
In conclusion, our results highlight the potential of D. melanogaster as a valuable model organism for evaluating the toxicity of essential oils. Our experiments revealed adverse effects of excessive doses of ginger, copaiba, and lavender essential oils, including neurotoxicity. Further investigations are warranted to explore their effects on other organs and their intestinal microbiota. However, our results also demonstrate the therapeutic potential of lavender essential oil, which not only prolonged the lifespan of D. melanogaster, but also induced an anti-inflammatory response without causing any damage to their brains. These observations suggest that lavender essential oil may be a promising candidate for the development of novel drugs.
Conclusion
In conclusion, the experiments with D. melanogaster not only showed that it is a reliable model for studies with essential oils, but also that even though essential oils can have therapeutic potential, they also have adverse effects. While higher doses of essential oils caused toxicity and reduced the lifespan of the animals, lower doses did not cause any significant negative effect and even increased their lifespan, for the lavender essential oil. The main adverse effect observed was neurotoxicity resulting in impaired climbing ability.
Lavender essential oil, on the other hand, proved to be a promising natural product for drug discovery, with the potential to induce an anti-inflammatory response in the flies without causing damage to their brain. These findings highlight the usefulness of D. melanogaster as a model organism for studying the toxicity and therapeutic properties of essential oils, a novelty, given that most tests using this model and essential oils aim at identifying possible larvicidal and insecticidal effects, and indicate that further testing is needed to fully explore their effects on other organs and their potential application in drug development.
Supporting information
Acknowledgments
We thank the members of the Genetics Laboratory and the Animal Facility Network of the Federal University of Uberlândia for their support during this project.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
The project was funded by the FAPEMIG agency (Project RED-00103-22). The funding was provided to support Lucas Matos Martins Bernardes as a scholarship holder. The funders did not participate in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Grand View Research. Global Essential Oils Market Size, Share & Trends Analysis Report by Product (Orange, Cornmint, Eucalyptus), Application (Medical, Food & Beverages, Spa & Relaxation), Sales Channel, Region, and Segment Forecasts, 2021–2028. 2021. [Google Scholar]
- 2.Ali B, Al-Wabel NA, Shams S, Ahamad A, Khan SA, Anwar F. Essential oils used in aromatherapy: A systemic review. Asian Pac J Trop Biomed [Internet]. 2015;5(8):601–11. Available from: 10.1016/j.apjtb.2015.05.007. [DOI] [Google Scholar]
- 3.Wang X, Shen Y, Thakur K, Han J, Zhang JG, Hu F, et al. Antibacterial Activity and Mechanism of Ginger Essential Oil against Escherichia coli and Staphylococcus aureus. Molecules. 2020;25(17). doi: 10.3390/molecules25173955 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.de Lima DAN, Pelegrini BB, Uechi FAA, Varago RC, Pimenta BB, de Souza Kaneshima AM, et al. Evaluation of antineoplasic activity of Zingiber officinale essential oil in the colorectal region of wistar rats. Asian Pacific J Cancer Prev. 2020;21(7):2141–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.do Carmo Silva L, Miranda MACM, de Freitas JV, Ferreira SFA, de Oliveira Lima EC, de Oliveira CMA, et al. Antifungal activity of Copaíba resin oil in solution and nanoemulsion against Paracoccidioides spp. Brazilian J Microbiol. 2020;51(1):125–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ames-Sibin AP, Barizão CL, Castro-Ghizoni C V., Silva FMS, Sá-Nakanishi AB, Bracht L, et al. β-Caryophyllene, the major constituent of copaiba oil, reduces systemic inflammation and oxidative stress in arthritic rats. Vol. 119, Journal of Cellular Biochemistry. 2018. p. 10262–77. [DOI] [PubMed] [Google Scholar]
- 7.Bahr T, Allred K, Martinez D, Rodriguez D, Winterton P. Effects of a massage-like essential oil application procedure using Copaiba and Deep Blue oils in individuals with hand arthritis. Complement Ther Clin Pract [Internet]. 2018;33(October):170–6. Available from: doi: 10.1016/j.ctcp.2018.10.004 [DOI] [PubMed] [Google Scholar]
- 8.Swamy MK, Akhtar MS, Sinniah UR. Antimicrobial properties of plant essential oils against human pathogens and their mode of action: An updated review. Evidence-based Complement Altern Med. 2016;2016. doi: 10.1155/2016/3012462 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Miguel MG. Antioxidant and anti-inflammatory activities of essential oils: A short review. Molecules. 2010;15(12):9252–87. doi: 10.3390/molecules15129252 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ramsey JT, Shropshire BC, Nagy TR, Chambers KD, Li Y, Korach KS. Essential oils and Health. Yale J Biol Med. 2020;93(2):291–305. doi: 10.1097/DER.0000000000000175 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ramsey JT, Li Y, Arao Y, Naidu A, Coons LA, DIaz A, et al. Lavender Products Associated with Premature Thelarche and Prepubertal Gynecomastia: Case Reports and Endocrine-Disrupting Chemical Activities. J Clin Endocrinol Metab. 2019;104(11):5393–405. doi: 10.1210/jc.2018-01880 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dosoky NS, Setzer WN. Maternal reproductive toxicity of some essential oils and their constituents. Int J Mol Sci. 2021;22(5):1–31. doi: 10.3390/ijms22052380 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lanzerstorfer P, Sandner G, Pitsch J, Mascher B, Aumiller T, Weghuber J. Acute, reproductive, and developmental toxicity of essential oils assessed with alternative in vitro and in vivo systems. Arch Toxicol [Internet]. 2021;95(2):673–91. Available from: doi: 10.1007/s00204-020-02945-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Fouyet S, Olivier E, Leproux P, Dutot M, Rat P. Evaluation of Placental Toxicity of Five Essential Oils and Their Potential Endocrine-Disrupting Effects. Curr Issues Mol Biol. 2022;44(7):2794–810. doi: 10.3390/cimb44070192 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hobson H. Animal research statistics for Great Britain, 2021 [Internet]. Urdestanding Animal Research. 2022. Available from: https://www.understandinganimalresearch.org.uk/news/animal-research-statistics-for-great-britain-2021. [Google Scholar]
- 16.Beckmann N, Maier P. Noninvasive Small Rodent Imaging: Significance for the 3R Principles. In: Small Animal Imaging. 2017. p. 47–57. [Google Scholar]
- 17.Kushalan S, D’Souza LC, Aloysius K, Sharma A, Hegde S. Toxicity Assessment of Curculigo orchioides Leaf Extract Using Drosophila melanogaster: A Preliminary Study. Int J Environ Res Public Health. 2022;19(22). doi: 10.3390/ijerph192215218 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Calap-Quintana P, González-Fernández J, Sebastiá-Ortega N, Llorens JV, Moltó MD. Drosophila melanogaster models of metal-related human diseases and metal toxicity. Int J Mol Sci. 2017;18(7). doi: 10.3390/ijms18071456 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Reiter LT, Potocki L, Chien S, Gribskov M, Bier E. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 2001;11(6):1114–25. doi: 10.1101/gr.169101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Adams MD, Celniker SE, Holt RA, Evans CA, Gocayne JD, Amanatides PG, et al. The genome sequence of Drosophila melanogaster. Science (80-). 2000;287(5461):2185–95. doi: 10.1126/science.287.5461.2185 [DOI] [PubMed] [Google Scholar]
- 21.Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118(2):401–15. doi: 10.1242/dev.118.2.401 [DOI] [PubMed] [Google Scholar]
- 22.Nichols CD, Becnel J, Pandey UB. Methods to Assay Drosophila Behavior. J Vis Exp. 2012;(61):3–7. doi: 10.3791/3795 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Batista LL, Malta SM, Guerra Silva HC, Borges LDF, Rocha LO, da Silva JR, et al. Kefir metabolites in a fly model for Alzheimer’s disease. Sci Rep [Internet]. 2021;11(1):1–12. Available from: 10.1038/s41598-021-90749-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Souza MT de, Souza MT de, Bernardi D, Oliveira D da C, Morais MC, Melo DJ de, et al. Essential Oil of Rosmarinus officinalis Ecotypes and Their Major Compounds: Insecticidal and Histological Assessment Against Drosophila suzukii and Their Impact on a Nontarget Parasitoid. J Econ Entomol. 2022;115(4):955–66. doi: 10.1093/jee/toab230 [DOI] [PubMed] [Google Scholar]
- 25.De Oliveira MRC, Barros LM, Duarte AE, De Lima Silva MG, Da Silva BAF, Pereira Bezerra AOB, et al. Gc-ms chemical characterization and in vitro evaluation of antioxidant and toxic effects using drosophila melanogaster model of the essential oil of lantana montevidensis (Spreng) briq. Med. 2019;55(5). doi: 10.3390/medicina55050194 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Souza MT de, Souza MT de, Morais MC, Oliveira D da C, Melo DJ de, Figueiredo L, et al. Essential Oils as a Source of Ecofriendly Insecticides for Drosophila suzukii (Diptera: Drosophilidae) and Their Potential Non-Target Effects. Molecules. 2022;27(19). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Gargano JW, Martin I, Bhandari P, Grotewiel MS. Rapid iterative negative geotaxis (RING): A new method for assessing age-related locomotor decline in Drosophila. Exp Gerontol. 2005;40(5):386–95. doi: 10.1016/j.exger.2005.02.005 [DOI] [PubMed] [Google Scholar]
- 28.Ferreiro MJ, Pérez C, Marchesano M, Ruiz S, Caputi A, Aguilera P, et al. Drosophila melanogaster white mutant w1118 undergo retinal degeneration. Front Neurosci. 2018;11(JAN):1–12. doi: 10.3389/fnins.2017.00732 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Malta SM, Batista LL, Silva HCG, Franco RR, Silva MH, Rodrigues TS, et al. Identification of bioactive peptides from a Brazilian kefir sample, and their anti-Alzheimer potential in Drosophila melanogaster. Sci Rep [Internet]. 2022;12(1):1–12. Available from: doi: 10.1038/s41598-022-15297-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Haditsch U, Roth T, Rodriguez L, Hancock S, Cecere T, Nguyen M, et al. Alzheimer’s Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains. J Alzheimer’s Dis. 2020;75(4):1301–17. doi: 10.3233/JAD-200393 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Morris PJ, Burke RD, Sharma AK, Lynch DC, Lemke-Boutcher LE, Mathew S, et al. A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801. Neurotoxicol Teratol. 2021;87:1–19. doi: 10.1016/j.ntt.2021.106993 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Tisserand R, Young R. Essential Oil Safety. A Guide for Health Care Professionals. Churchill Livingstone. 2014. 783 p. [Google Scholar]
- 33.Sachetti CG, Fascineli ML, Sampaio JA, Lameira OA, Caldas ED. Avaliação da toxicidade aguda e potencial neurotóxico do óleo-resina de copaíba (Copaifera reticulata Ducke, Fabaceae). Rev Bras Farmacogn. 2009;19(4):937–41. [Google Scholar]
- 34.Silva MAC, dos Anjos Melo DF, de Oliveira SAM, Cruz A de C, da Conceição EC, de Paula JR, et al. Acute and a 28-repeated dose toxicity study of commercial oleoresin from Copaifera sp. in rodents. Adv Tradit Med [Internet]. 2022;22(4):739–47. Available from: 10.1007/s13596-021-00601-7. [DOI] [Google Scholar]
- 35.Akinyemi AJ, Adeniyi PA. Effect of Essential Oils from Ginger (Zingiber officinale) and Turmeric (Curcuma longa) Rhizomes on Some Inflammatory Biomarkers in Cadmium Induced Neurotoxicity in Rats. J Toxicol. 2018;2018. doi: 10.1155/2018/4109491 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Pandur E, Balatinácz A, Micalizzi G, Mondello L, Horváth A, Sipos K, et al. Anti-inflammatory effect of lavender (Lavandula angustifolia Mill.) essential oil prepared during different plant phenophases on THP-1 macrophages. BMC Complement Med Ther [Internet]. 2021;21(1):1–17. Available from: 10.1186/s12906-021-03461-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Horváth A, Pandur E, Sipos K, Micalizzi G, Mondello L, Böszörményi A, et al. Anti-inflammatory effects of lavender and eucalyptus essential oils on the in vitro cell culture model of bladder pain syndrome using T24 cells. BMC Complement Med Ther [Internet]. 2022;22(1):1–14. Available from: 10.1186/s12906-022-03604-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Lucca LG, de Matos SP, Kreutz T, Teixeira HF, Veiga VF, de Araújo B V., et al. Anti - inflammatory Effect from a Hydrogel Containing Nanoemulsified Copaiba oil (Copaifera multijuga Hayne). AAPS PharmSciTech. 2018;19(2):522–30. [DOI] [PubMed] [Google Scholar]
- 39.Tue NT, Dat TQ, Ly LL, Anh VD, Yoshida H. Insights from Drosophila melanogaster model of Alzheimer’s disease. Front Biosci. 2020;25:134–46. doi: 10.2741/4798 [DOI] [PubMed] [Google Scholar]
- 40.Bolus H, Crocker K, Boekhoff-Falk G, Chtarbanova S. Modeling neurodegenerative disorders in Drosophila melanogaster. Int J Mol Sci. 2020;21(9). doi: 10.3390/ijms21093055 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Aryal B, Lee Y. Disease model organism for Parkinson disease: Drosophila melanogaster. BMB Rep. 2019;52(4):250–8. doi: 10.5483/BMBRep.2019.52.4.204 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Belvoncikova P, Maronek M, Gardlik R. Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases. Int J Mol Sci. 2022;23(18). doi: 10.3390/ijms231810729 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Chen Y, Zhou J, Wang L. Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol. 2021;11(March):1–12. doi: 10.3389/fcimb.2021.625913 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Iatcu CO, Steen A, Covasa M. Gut microbiota and complications of type-2 diabetes. Nutrients. 2022;14(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Varesi A, Pierella E, Romeo M, Piccini GB, Alfano C, Bjørklund G, et al. The Potential Role of Gut Microbiota in Alzheimer’s Disease: from Diagnosis to Treatment. Nutrients. 2022;14(3):1–27. doi: 10.3390/nu14030668 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Chang L, Wei Y, Hashimoto K. Brain–gut–microbiota axis in depression: A historical overview and future directions. Brain Res Bull [Internet]. 2022;182(January):44–56. Available from: doi: 10.1016/j.brainresbull.2022.02.004 [DOI] [PubMed] [Google Scholar]
- 47.Klann EM, Dissanayake U, Gurrala A, Farrer M, Shukla AW, Ramirez-Zamora A, et al. The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review. Front Aging Neurosci. 2022;13(January):1–17. doi: 10.3389/fnagi.2021.782082 [DOI] [PMC free article] [PubMed] [Google Scholar]